SARomics Biostructures

SARomics Biostructures

Private
LundHealthcare & Life Scienceshttps://www.saromics.com/

Last Round

Grant

Apr 2, 2020

Total Funding Raised

$1.53M

Momentum Score

25 /100

Company Overview

SARomics Biostructures is a biotechnology company that provides structural biology and drug discovery outsourcing services, including X-ray crystallography and NMR spectroscopy, to support the entire drug development process.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROstructural biologydrug discovery servicesX-ray crystallographyNMR spectroscopyprotein structure determinationfragment-based drug discoveryFBDDfragment screeninglead optimizationhit identificationcomputational chemistryvirtual screeningepitope mappinghigher order structure analysisHOS analysisDNA-encoded library screeningDEL screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SARomics Biostructures Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SARomics Biostructures Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantApr 2, 2020
GrantOct 5, 2017
DebtMar 6, 2014
GrantFeb 5, 2014
GrantApr 1, 2013
Seed
Sep 12, 2012

Key People

Founding team and executive leadership

Björn Walse

CEO

Executive Team

SARomics Biostructures Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 19% QoQ, from 21 to 25 employees.

  • Nov 7, 2025

    Monthly visitors increased 49% MoM.

SARomics Biostructures Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SARomics Biostructures Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SARomics Biostructures's valuation, stock price, and market status.

Firmographic Details

HeadquartersLund
Employee Range25
Year Founded2006
Last FundingApr 2, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.